GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BG Medicine Inc (OTCPK:BGMD) » Definitions » Asset Turnover

BG Medicine (BG Medicine) Asset Turnover : 0.11 (As of Dec. 2015)


View and export this data going back to 2011. Start your Free Trial

What is BG Medicine Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. BG Medicine's Revenue for the three months ended in Dec. 2015 was $0.29 Mil. BG Medicine's Total Assets for the quarter that ended in Dec. 2015 was $2.74 Mil. Therefore, BG Medicine's Asset Turnover for the quarter that ended in Dec. 2015 was 0.11.

Asset Turnover is linked to ROE % through Du Pont Formula. BG Medicine's annualized ROE % for the quarter that ended in Dec. 2015 was 222.03%. It is also linked to ROA % through Du Pont Formula. BG Medicine's annualized ROA % for the quarter that ended in Dec. 2015 was -131.46%.


BG Medicine Asset Turnover Historical Data

The historical data trend for BG Medicine's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BG Medicine Asset Turnover Chart

BG Medicine Annual Data
Trend Dec05 Dec06 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.14 0.33 0.38 0.43

BG Medicine Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.11 0.26 0.14 0.11

Competitive Comparison of BG Medicine's Asset Turnover

For the Medical Instruments & Supplies subindustry, BG Medicine's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BG Medicine's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's Asset Turnover distribution charts can be found below:

* The bar in red indicates where BG Medicine's Asset Turnover falls into.



BG Medicine Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

BG Medicine's Asset Turnover for the fiscal year that ended in Dec. 2015 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2015 )/( (Total Assets (A: Dec. 2014 )+Total Assets (A: Dec. 2015 ))/ count )
=1.566/( (5.229+2.133)/ 2 )
=1.566/3.681
=0.43

BG Medicine's Asset Turnover for the quarter that ended in Dec. 2015 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2015 )/( (Total Assets (Q: Sep. 2015 )+Total Assets (Q: Dec. 2015 ))/ count )
=0.29/( (3.356+2.133)/ 2 )
=0.29/2.7445
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


BG Medicine  (OTCPK:BGMD) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

BG Medicine's annulized ROE % for the quarter that ended in Dec. 2015 is

ROE %**(Q: Dec. 2015 )
=Net Income/Total Stockholders Equity
=-3.608/-1.625
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-3.608 / 1.16)*(1.16 / 2.7445)*(2.7445/ -1.625)
=Net Margin %*Asset Turnover*Equity Multiplier
=-311.03 %*0.4227*-1.6889
=ROA %*Equity Multiplier
=-131.46 %*-1.6889
=222.03 %

Note: The Net Income data used here is four times the quarterly (Dec. 2015) net income data. The Revenue data used here is four times the quarterly (Dec. 2015) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

BG Medicine's annulized ROA % for the quarter that ended in Dec. 2015 is

ROA %(Q: Dec. 2015 )
=Net Income/Total Assets
=-3.608/2.7445
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-3.608 / 1.16)*(1.16 / 2.7445)
=Net Margin %*Asset Turnover
=-311.03 %*0.4227
=-131.46 %

Note: The Net Income data used here is four times the quarterly (Dec. 2015) net income data. The Revenue data used here is four times the quarterly (Dec. 2015) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


BG Medicine Asset Turnover Related Terms

Thank you for viewing the detailed overview of BG Medicine's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


BG Medicine (BG Medicine) Business Description

Traded in Other Exchanges
N/A
Address
303 Wyman Street, Suite 300, Waltham, MA, USA, 02451
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Executives
Jeffrey R Luber director 100 CAMPUS DRIVE, C/O EXACT SCIENCES CORP, MARLBOROUGH MA 01752
Noubar Afeyan director, 10 percent owner C/O FLAGSHIP PIONEERING, INC., 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142
Stelios Papadopoulos director 3 SOMERSET DRIVE SOUTH, GREAT NECK NY 11020
Harry W Wilcox director ONE KENDALL SQ, BLDG 700, CAMBRIDGE MA 02139
Agtc Partners, L.p. 10 percent owner C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Newcogen Group, Inc. 10 percent owner C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Applied Genomic Technology Capital Fund Lp 10 percent owner C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Flagship Pioneering Inc. 10 percent owner 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142
Agtc Advisors Fund Lp 10 percent owner ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142
Kania Edwin M Jr 10 percent owner
Flagship Ventures Fund 2007, L.p. 10 percent owner 55 CAMBRIDGE PARKWAY, 8TH FLOOR, CAMBRIDGE MA 02142
Flagship Ventures 2007 General Partner Llc 10 percent owner 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142
Brian S Posner director 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Stephane Bancel director 320 BENT STREET, CAMBRIDGE MA 02141
Harris Timothy J.r. director C/O BG MEDICINE, 610 LINCOLN STREET NORTH, WALTHAM MA 02451

BG Medicine (BG Medicine) Headlines

No Headlines